North America Glycomics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)

Code: BMIRE00027262 | Pages: 170 | Industry: Biotechnology | Date: Oct 2022 | Type: Regional

The North America glycomics market is expected to grow from US$ 598.44 million in 2022 to US$ 1,289.32 million by 2028; it is estimated to grow at a CAGR of 13.6% from 2022 to 2028.

 As scientists have concentrated their efforts on glycomics, they have started to learn important details about the functions of glycans and glycosylation in the body, including cellular communication, and what these factors might reveal about disease development and diagnostics. The largest and fastest-growing application category is drug discovery and development, mostly due to the rise in R&D by pharmaceutical and biotechnology firms and the expansion of drug discovery research activities in university research institutions. For instance, in March 2021, 48Hour Discovery (48HD) and CQDM announced that the firms received an award of US$ 800,000 for peptide drug development utilizing its unique drug discovery platform. The CQDM Quantum Leap initiative, which encourages research into cutting-edge technologies, methods, and platforms that speed up or expedite drug discovery and development, provided funding for the two-year study. Merck, a CQDM member, is financing the study. The University of Alberta and 48HD will work together on the project. Additionally, GlycoNet—a Network of Centers of Excellence centered at the University of Alberta for Glycomics Research—is providing the funds to enhance Canadians' quality of life. In March 2022, researchers from GlycoNet developed a novel combination medication for Sanfilippo syndrome, which is showing encouraging preclinical outcomes. Several advancements show that glycomics has the potential to provide rapid and accurate diagnostics methods that transcend diverse clinical indications and complex conditions. Therefore, the use of glycomics in drug development across the region is acting as a key market driver.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America glycomics market. The North America glycomics market is expected to grow at a good CAGR during the forecast period. 

 

North America Glycomics Market Revenue and Forecast to 2028 (US$ Million)  

Get more information on this report :

 

 

 

North America Glycomics Market Segmentation   

 

The North America glycomics market is segmented based on product, application, end user, and country. Based on product, the North America glycomics market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment dominated the market in 2022. The enzymes segment is further segmented into glycosidases, glycosyl transferases, sialyltransferases, neuraminidases, and others. The instruments segment is also segmented into mass spectrometers, MALDI-TOF, HPLC, lectin arrays, antibody arrays, and others. Similarly, the kits segment is segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Furthermore, the reagents segment is segmented into oligosaccharides, monosaccharides, glycoproteins, and others. Based on application, the North America glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment dominated the market in 2022. Based on end user, the North America glycomics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment dominated the market in 2022. Based on country, the North America glycomics market has been categorized into the US, Canada, and Mexico. The US dominated the market in 2022.

 

Agilent Technologies, Inc.; Bruker Corporation; MERCK KGaA; New England Biolabs; S-BIO (Sumitomo Bakelite Co., Ltd.); Shimadzu Corporation; Takara Bio Inc.; Thermo Fisher Scientific Inc.; and Waters Corporation are among the leading companies in the North America glycomics market.  

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Glycomics Market – By Product

1.3.2        North America Glycomics Market – By Application

1.3.3        North America Glycomics Market – By End User

1.3.4        North America Glycomics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Glycomics Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Glycomics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increased Glycomics Research and Expanding R&D Investments

5.1.2        Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes

5.2         Market Restraints

5.2.1        High Cost of Equipment and Shortage of skilled Professionals

5.3         Market Opportunities

5.3.1        Wide Applications of Glycomics

5.4         Future Trends

5.4.1        New tools in Glycomics Research

5.5         Impact Analysis

6.           Glycomics Market– North America Analysis

6.1         North America Glycomics Market Revenue Forecast and Analysis

7.           North America Glycomics Market Analysis – By Product

7.1         Overview

7.2         North America Glycomics Market, By Product 2022 & 2028 (%)

7.3         Enzymes

7.3.1        Overview

7.3.2        Enzymes Revenue and Forecast to 2028 (US$ Million)

7.3.3        Glycosidases

7.3.3.1          Overview

7.3.3.2          Glycosidases - Revenue and Forecast to 2028 (US$ Million)

7.3.4        Glycosyltransferases

7.3.4.1          Overview

7.3.4.2          Glycosyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.5        Sialyltransferases

7.3.5.1          Overview

7.3.5.2          Sialyltransferases - Revenue and Forecast to 2028 (US$ Million)

7.3.6        Neuraminidases

7.3.6.1          Overview

7.3.6.2          Neuraminidases - Revenue and Forecast to 2028 (US$ Million)

7.3.7        Others

7.3.7.1          Overview

7.3.7.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments - Revenue and Forecast to 2028 (US$ Million)

7.4.3        Mass Spectrometers

7.4.3.1          Overview

7.4.3.2          Mass Spectrometers- Revenue and Forecast to 2028 (US$ Million)

7.4.4        MALDI-TOF

7.4.4.1          Overview

7.4.4.2          MALDI-TOF - Revenue and Forecast to 2028 (US$ Million)

7.4.5        High-Performance Liquid Chromatography (HPLC)

7.4.5.1          Overview

7.4.5.2          High-Performance Liquid Chromatography (HPLC)- Revenue and Forecast to 2028 (US$ Million)

7.4.6        Lectin Arrays

7.4.6.1          Overview

7.4.6.2          Lectin Arrays- Revenue and Forecast to 2028 (US$ Million)

7.4.7        Antibody Arrays

7.4.7.1          Overview

7.4.7.2          Antibody Arrays - Revenue and Forecast to 2028 (US$ Million)

7.4.8        Others

7.4.8.1          Overview

7.4.8.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.5         Kits

7.5.1        Overview

7.5.2        Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.3        Glycan Release Kits

7.5.3.1          Overview

7.5.3.2          Glycan Release Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.4        Glycan Labelling Kits

7.5.4.1          Overview

7.5.4.2          Glycan Labelling Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.5        Glycan Purification Kits

7.5.5.1          Overview

7.5.5.2          Glycan Purification Kits - Revenue and Forecast to 2028 (US$ Million)

7.5.6        Others

7.5.6.1          Overview

7.5.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

7.6         Reagents

7.6.1        Overview

7.6.2        Reagents - Revenue and Forecast to 2028 (US$ Million)

7.6.3        Oligosaccharides

7.6.3.1          Overview

7.6.3.2          Oligosaccharides- Revenue and Forecast to 2028 (US$ Million)

7.6.4        Monosaccharides

7.6.4.1          Overview

7.6.4.2          Monosaccharides - Revenue and Forecast to 2028 (US$ Million)

7.6.5        Glycoproteins

7.6.5.1          Overview

7.6.5.2          Glycoproteins - Revenue and Forecast to 2028 (US$ Million)

7.6.6        Others

7.6.6.1          Overview

7.6.6.2          Others- Revenue and Forecast to 2028 (US$ Million)

8.           North America Glycomics Market Analysis – By Application

8.1         Overview

8.2         North America Glycomics Market, By Application 2022 & 2028 (%)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Drug Discovery and Development - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Diagnostics

8.4.1        Overview

8.4.2        Diagnostics - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunology

8.5.1        Overview

8.5.2        Immunology - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Cancer

8.6.1        Overview

8.6.2        Cancer - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Glycomics Market Analysis – By End User

9.1         Overview

9.2         North America Glycomics Market, By End User 2022 & 2028 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

9.4         Contract Research Organizations

9.4.1        Overview

9.4.2        Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

9.5         Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

10.        North America Glycomics Market – Country Analysis

10.1      Overview

10.1.2     North America: Glycomics Market, by Country, 2022 & 2028 (%)

10.1.2.1       US: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       US: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       US: Glycomics Market, by Product, 2020-2028 (US$ Million)

10.1.2.1.3.1    US: Glycomics Market, by Enzymes, 2020-2028 (US$ Million)

10.1.2.1.3.2    US: Glycomics Market, by Instruments, 2020-2028 (US$ Million)

10.1.2.1.3.3    US: Glycomics Market, by Kits, 2020-2028 (US$ Million)

10.1.2.1.3.4    US: Glycomics Market, by Reagents, 2020-2028 (US$ Million)

10.1.2.1.4       US: Glycomics Market, by Application, 2020-2028 (US$ Million)

10.1.2.1.5       US: Glycomics Market, by End-User, 2020-2028 (US$ Million)

10.1.2.2       Canada: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Canada: Glycomics Market, by Product, 2020-2028 (US$ Million)

10.1.2.2.3.1    Canada: Glycomics Market, by Enzymes, 2020-2028 (US$ Million)

10.1.2.2.3.2    Canada: Glycomics Market, by Instruments, 2020-2028 (US$ Million)

10.1.2.2.3.3    Canada: Glycomics Market, by Kits, 2020-2028 (US$ Million)

10.1.2.2.3.4    Canada: Glycomics Market, by Reagents, 2020-2028 (US$ Million)

10.1.2.2.4       Canada: Glycomics Market, by Application, 2020-2028 (US$ Million)

10.1.2.2.5       Canada: Glycomics Market, by End-User, 2020-2028 (US$ Million)

10.1.2.3       Mexico: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Mexico: Glycomics Market, by Product, 2020-2028 (US$ Million)

10.1.2.3.3.1    Mexico: Glycomics Market, by Enzymes, 2020-2028 (US$ Million)

10.1.2.3.3.2    Mexico: Glycomics Market, by Instruments, 2020-2028 (US$ Million)

10.1.2.3.3.3    Mexico: Glycomics Market, by Kits, 2020-2028 (US$ Million)

10.1.2.3.3.4    Mexico: Glycomics Market, by Reagents, 2020-2028 (US$ Million)

10.1.2.3.4       Mexico: Glycomics Market, by Application, 2020-2028 (US$ Million)

10.1.2.3.5       Mexico: Glycomics Market, by End-User, 2020-2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

11.4      Inorganic Developments in the Glycomics Market

12.        Company Profiles

12.1      MERCK KGaA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Agilent Technologies, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      New England Biolabs

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Thermo Fisher Scientific Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Waters Corporation

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Bruker Corporation

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Takara Bio Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      S-BIO (Sumitomo Bakelite Co., Ltd.)

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Shimadzu Corporation

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             North America Glycomics Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             US Glycomics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Glycomics Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

Table 5.             US Glycomics Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 6.             US Glycomics Market, by Reagents – Revenue and Forecast to 2028 (USD Million)

Table 7.             US Glycomics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             US Glycomics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada Glycomics Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

Table 12.          Canada Glycomics Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada Glycomics Market, by Reagents – Revenue and Forecast to 2028 (USD Million)

Table 14.          Canada Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Canada Glycomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (USD Million)

Table 18.          Mexico Glycomics Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

Table 19.          Mexico Glycomics Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 20.          Mexico Glycomics Market, by Reagents – Revenue and Forecast to 2028 (USD Million)

Table 21.          Mexico Glycomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 22.          Mexico Glycomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Organic Developments in the Glycomics Market

Table 24.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           North America Glycomics Market Segmentation

Figure 2.           North America Glycomics Market, By Country

Figure 3.           North America Glycomics Market Overview

Figure 4.           North America Glycomics Market, By Product

Figure 5.           North America Glycomics Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           North America Glycomics Market Impact Analysis of Driver and Restraints

Figure 8.           North America Glycomics Market – Revenue Forecast and Analysis

Figure 9.           North America Glycomics Market, by Product 2022 & 2028 (%)

Figure 10.        North America Enzymes Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        North America Glycosidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        North America Glycosyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America Sialyltransferases - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        North America Neuraminidases - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        North America Instruments - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        North America Mass Spectrometers - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        North America MALDI-TOF - Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        North America High-Performance Liquid Chromatography (HPLC)- Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        North America Lectin Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        North America Antibody Arrays - Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        North America Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        North America Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        North America Glycan Release Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        North America Glycan Labelling Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        North America Glycan Purification Kits - Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        North America Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        North America Reagents - Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        North America Oligosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        North America Monosaccharides - Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        North America Glycoproteins - Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        North America Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        North America Glycomics Market, by Application 2022 & 2028 (%)

Figure 34.        North America Drug Discovery and Development - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        North America Diagnostics - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        North America Immunology - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        North America Cancer - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        North America Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        North America Glycomics Market, by End User 2022 & 2028 (%)

Figure 40.        North America Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 41.        North America Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 42.        North America Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 43.        North America: Glycomics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 44.        North America: Glycomics Market, by Country, 2022 & 2028 (%)

Figure 45.        US: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Canada: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.        Mexico: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

  1. Agilent Technologies, Inc.
  2. Bruker Corporation
  3. MERCK KGaA
  4. New England Biolabs
  5. S-BIO (Sumitomo Bakelite Co., Ltd.)
  6. Shimadzu Corporation
  7. Takara Bio Inc.
  8. Thermo Fisher Scientific Inc.
  9. Waters Corporation  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000